USP12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62925228863742E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.13209996721997E-09 |
Normal-vs-Stage2 |
4.640100E-04 |
Normal-vs-Stage3 |
1.18793863634892E-14 |
Normal-vs-Stage4 |
1.68076663698002E-12 |
Stage1-vs-Stage2 |
6.986000E-01 |
Stage1-vs-Stage3 |
8.224600E-04 |
Stage1-vs-Stage4 |
1.212800E-04 |
Stage2-vs-Stage3 |
6.656100E-02 |
Stage2-vs-Stage4 |
2.016100E-02 |
Stage3-vs-Stage4 |
3.824400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.6399329650958E-14 |
Normal-vs-AfricanAmerican |
4.72709649201875E-11 |
Normal-vs-Asian |
2.255400E-01 |
Caucasian-vs-AfricanAmerican |
3.428000E-02 |
Caucasian-vs-Asian |
5.468200E-01 |
AfricanAmerican-vs-Asian |
1.261620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62492241884138E-12 |
Normal-vs-Female |
9.97070004338241E-09 |
Male-vs-Female |
5.337800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.1162961100506E-11 |
Normal-vs-Age(41-60Yrs) |
2.0047996596162E-10 |
Normal-vs-Age(61-80Yrs) |
4.2410519540681E-14 |
Normal-vs-Age(81-100Yrs) |
2.883400E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.764400E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.302300E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.883600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.427000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.059600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.242200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.830600E-01 |
Normal-vs-Grade 2 |
3.47749999907165E-08 |
Normal-vs-Grade 3 |
1.35447209004269E-14 |
Normal-vs-Grade 4 |
1.63002944475465E-12 |
Grade 1-vs-Grade 2 |
2.313600E-01 |
Grade 1-vs-Grade 3 |
2.953700E-02 |
Grade 1-vs-Grade 4 |
1.397490E-03 |
Grade 2-vs-Grade 3 |
6.798600E-03 |
Grade 2-vs-Grade 4 |
1.67596999999242E-05 |
Grade 3-vs-Grade 4 |
1.385580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.589800E-04 |
Normal-vs-ccB subtype |
1.89848137210902E-14 |
ccA subtype-vs-ccB subtype |
3.39770000001849E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.25361959596648E-12 |
Normal-vs-N1 |
3.830100E-04 |
N0-vs-N1 |
8.805500E-02 |
|
|